Search Results for: CRISPR
Special Organ Transplant
Xenotransplantation-A Boon for the Needy or an Ethical Conundrum?
2021-11-01
Policy Rare Disease
Big Pharma and Non-Profits Join NIH, FDA in New Rare Diseases Drive
2021-10-28
Special Prime Editing
New Age Gene Editors Take Us Closer to CRISPR-Based Gene Therapy
2021-10-28
Funding Cell Therapy
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
Licensing CRISPR
Vertex Signs $700 Million worth CRISPR Pact with Jennifer Doudna Co-founded Gene Editing Firm
2021-10-26
Feature Microbiome
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Trials & Approvals CRISPR
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Trials & Approvals Sleep Apnea
Apnimed’s Oral Drug for Obstructive Sleep Apnea Registers Encouraging Outcomes in Two Phase 2 Trials
2021-10-14
M&A
Supernus Invests $400 Million to Acquire New Parkinson’s Assets from Adamas
2021-10-12
Special
Landmark CRISPR Trial Shows Promise Against Fighting Blindness, but Is It a Cure?
2021-10-08
Special Biofuel
From Food to Fuel, Are Algae the Future of Biotech?
2021-10-08
Special Space Biology
Research Endeavors in Space Biology – Are We Gearing Towards Another Biological Moonshot?
2021-09-21
Interviews RNA Editing
Revealing the Underestimated Potential of Natural RNA Editing – An Interview with Dr. Trees-Juen Chuang
2021-09-17
MD Anderson to Develop Microbiome Cancer Therapeutics with CRISPR Gene-Editing
2021-09-14
Funding
Jennifer Doudna’s Gene Editing Firm Mammoth Biosciences Attains Unicorn Status
2021-09-11
1 … 4 5 6 7 8 … 16
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top